DNLI logo

Denali Therapeutics Inc. (DNLI)

Profile

Full Name

Denali Therapeutics Inc.

Ticker

NASDAQ: DNLI

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

December 8, 2017

Indexes

Not included

Website

https://www.denalitherapeutics.com

Employees

443

Key Details

Price

$13.44(-2.82%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$2.57(-142.45% YoY)

PE ratio

-

Next earnings date

Nov 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $13.44
    DNLI price is $13.44

    30-Day Relative Volume

    1.11
    DNLI 30-day relative volume is 1.11

    Price Performance

    Price Most recent change

    -2.82%
    DNLI price was down -2.82% on Aug 1, 2025

    Price YTD change

    -34.05%
    DNLI price is down -34.05% since January 1st

    Price 1-year change

    -42.39%
    DNLI price is down -42.39% year-on-year

    Price 3-year change

    -58.99%
    DNLI price is down -58.99% over the past 3 years

    Price Range

    Price All-time high

    $93.94
    DNLI price is currently -85.69% below its historical high of $93.94

    Price 3-year low

    $10.57
    DNLI price is currently +27.15% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.95B
    DNLI market capitalization is $1.95 billion

    Market cap 3-year change

    -51.7%
    DNLI market capitalization is down -51.7% over the past 3 years

    Market cap All-time high

    $11.22B
    DNLI market capitalization is currently -82.60% below its historical high of $11.22 billion

    Market cap sector rank

    82.25%
    DNLI market capitalization is higher than 82.25% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.47%
    DNLI shares outstanding is up +1.47% year-on-year

    Shares Outstanding 3-Year Change

    +17.78%
    DNLI shares outstanding is up +17.78% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.47
    DNLI beta is 1.47

    200-day SMA

    $18.70
    DNLI price is currently -28.13% below its 200-day simple moving average

    50-day SMA

    $14.18
    DNLI price is currently -5.20% below its 50-day simple moving average

    RSI

    41.73
    DNLI 14-day relative strength index is 41.73

    Volume

    1.11
    DNLI 30-day relative volume is 1.11

    ATR

    $0.69
    DNLI average true range is $0.69

    10-day Historical Volatility

    37.29%
    DNLI 10-day historical volatility is 37.29%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    DNLI annual revenue value is unknown

    Revenue Analysts estimate

    $19.62M
    DNLI annual revenue is currently equal to the consensus analysts' forecast

    Revenue 1-year change

    -
    DNLI annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    DNLI annual revenue is unknown

    EPS

    EPS

    -$2.57
    DNLI annual earnings per share is -$2.57

    EPS Analysts estimate

    -$3.06
    DNLI annual earnings per share is currently -15.96% lower than the consensus analysts' forecast

    EPS 1-year change

    -142.45%
    DNLI annual earnings per share is down -142.45% year-on-year

    EPS Sector rank

    34.61%
    DNLI annual earnings per share is higher than 34.61% of companies in Healthcare sector

    Profit

    Gross profit

    -
    DNLI annual gross profit value is unknown

    Gross margin

    -
    DNLI annual gross profit margin value is unknown

    Operating profit

    -$501.88M
    DNLI annual operating income is -$501.88 million

    Operating margin

    -
    DNLI annual operating profit margin value is unknown

    Net income

    -$422.77M
    DNLI annual net profit is -$422.77 million

    Net margin

    -
    DNLI annual net profit margin value is unknown

    Expenses

    Total expenses

    $501.88M
    DNLI annual total expenses is $501.88 million

    Operating expenses

    $501.88M
    DNLI annual total operating expenses is $501.88 million

    Cost of goods sold

    -
    DNLI annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $105.44M
    DNLI annual SGA is $105.44 million

    Depreciation and amortization

    $8.99M
    DNLI annual depreciation & amortization is $8.99 million

    Interest expense

    -
    DNLI annual interest expense value is unknown

    Income tax

    $68.00K
    DNLI annual income tax is $68.00 thousand

    EBIT & EBITDA

    EBIT

    -$501.88M
    DNLI annual earnings before interest & taxes is -$501.88 million

    EBITDA

    -$492.89M
    DNLI annual EBITDA is -$492.89 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.37B
    DNLI annual total assets is $1.37 billion

    Non current assets

    $509.74M
    DNLI annual long term assets is $509.74 million

    Current assets

    $864.44M
    DNLI annual total current assets is $864.44 million

    Cash and cash equivalents

    $174.96M
    DNLI annual cash & cash equivalents is $174.96 million

    Accounts receivable

    $2.17M
    DNLI annual accounts receivable is $2.17 million

    Inventory

    -
    DNLI annual inventory value is unknown

    Liabilities

    Total liabilities

    $144.50M
    DNLI annual total liabilities is $144.50 million

    Long term liabilities

    $42.29M
    DNLI annual total long term liabilities is $42.29 million

    Current liabilities

    $102.21M
    DNLI annual total current liabilities is $102.21 million

    Accounts payable

    $11.14M
    DNLI annual accounts payable is $11.14 million

    Debt

    Total debt

    $48.71M
    DNLI annual total debt is $48.71 million

    Total debt 1-year change

    -6.76%
    DNLI annual total debt is down -6.76% year-on-year

    Long term debt

    $36.67M
    DNLI annual long term debt is $36.67 million

    Short term debt

    $12.03M
    DNLI annual short term debt is $12.03 million

    Equity & Capital

    Shareholders equity

    $1.23B
    DNLI annual stockholders equity is $1.23 billion

    Book value

    $1.23B
    DNLI annual book value is $1.23 billion

    Retained earnings

    -$1.54B
    DNLI annual retained earnings is -$1.54 billion

    Working capital

    $762.23M
    DNLI annual working capital is $762.23 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$347.69M
    DNLI annual cash flow from operations is -$347.69 million

    Cash from operations 1-year change

    +2.88%
    DNLI annual cash flow from operations is up +2.88% year-on-year

    Cash from investing

    -$88.76M
    DNLI annual cash flow from investing activities is -$88.76 million

    Cash from investing 1-year change

    -135.6%
    DNLI annual cash flow from investing activities is down -135.6% year-on-year

    Cash from financing

    $484.30M
    DNLI annual cash flow from financing activities is $484.30 million

    Cash from financing 1-year change

    +2617.76%
    DNLI annual cash flow from financing activities is up +2617.76% year-on-year

    CAPEX

    CAPEX

    -
    DNLI annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    DNLI annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$363.61M
    DNLI annual free cash flow is -$363.61 million

    Free cash flow 1-year change

    +1.97%
    DNLI annual free cash flow is up +1.97% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    DNLI annual gross profit margin value is unknown

    Operating margin

    -
    DNLI annual operating profit margin value is unknown

    Net margin

    -
    DNLI annual net profit margin value is unknown

    ROA & ROE

    ROA

    -30.77%
    DNLI annual return on assets is -30.77%

    ROE

    -34.38%
    DNLI annual return on equity is -34.38%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    DNLI price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    DNLI price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.74
    DNLI price to book ratio is 1.74

    PB ratio Sector rank

    52.37%
    DNLI price to book ratio is higher than 52.37% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    DNLI price to sales ratio value is unknown

    PS ratio Sector rank

    -
    DNLI price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $1.94B
    DNLI enterprise value is $1.94 billion

    Enterprise value Sector rank

    81.51%
    DNLI enterprise value is higher than 81.51% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -3.85
    DNLI EV/EBITDA is -3.85

    EV/EBITDA Sector rank

    27.23%
    DNLI EV/EBITDA is higher than 27.23% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    8.46
    DNLI annual current ratio is 8.46

    Quick ratio

    -
    DNLI annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.04
    DNLI annual debt to equity ratio is 0.04

    Interest coverage ratio

    -
    DNLI annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    DNLI piotroski f-score value is unknown

    Altman Z-Score

    -
    DNLI altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    May 19, 25 B of A Securities
    Buy
    May 8, 25 Baird
    Outperform
    May 7, 25 Wedbush
    Outperform
    May 7, 25 HC Wainwright & Co.
    Buy
    Mar 10, 25 B of A Securities
    Buy
    Mar 5, 25 B. Riley Securities
    Buy
    Mar 3, 25 Oppenheimer
    Outperform
    Feb 28, 25 HC Wainwright & Co.
    Buy
    Feb 11, 25 Deutsche Bank
    Buy
    Jan 28, 25 Goldman Sachs
    Buy

    Institutional Ownership

    Screeners with DNLI included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    Earnings today
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    • What is the ticker symbol for Denali Therapeutics Inc.?
    • Does Denali Therapeutics Inc. pay dividends?
    • What sector is Denali Therapeutics Inc. in?
    • What industry is Denali Therapeutics Inc. in?
    • What country is Denali Therapeutics Inc. based in?
    • When did Denali Therapeutics Inc. go public?
    • Is Denali Therapeutics Inc. in the S&P 500?
    • Is Denali Therapeutics Inc. in the NASDAQ 100?
    • Is Denali Therapeutics Inc. in the Dow Jones?
    • When was Denali Therapeutics Inc.'s last earnings report?
    • When does Denali Therapeutics Inc. report earnings?

    What is the ticker symbol for Denali Therapeutics Inc.?

    The ticker symbol for Denali Therapeutics Inc. is NASDAQ:DNLI

    Does Denali Therapeutics Inc. pay dividends?

    No, Denali Therapeutics Inc. does not pay dividends

    What sector is Denali Therapeutics Inc. in?

    Denali Therapeutics Inc. is in the Healthcare sector

    What industry is Denali Therapeutics Inc. in?

    Denali Therapeutics Inc. is in the Biotechnology industry

    What country is Denali Therapeutics Inc. based in?

    Denali Therapeutics Inc. is headquartered in United States

    When did Denali Therapeutics Inc. go public?

    Denali Therapeutics Inc.'s initial public offering (IPO) was on December 8, 2017

    Is Denali Therapeutics Inc. in the S&P 500?

    No, Denali Therapeutics Inc. is not included in the S&P 500 index

    Is Denali Therapeutics Inc. in the NASDAQ 100?

    No, Denali Therapeutics Inc. is not included in the NASDAQ 100 index

    Is Denali Therapeutics Inc. in the Dow Jones?

    No, Denali Therapeutics Inc. is not included in the Dow Jones index

    When was Denali Therapeutics Inc.'s last earnings report?

    Denali Therapeutics Inc.'s most recent earnings report was on May 6, 2025

    When does Denali Therapeutics Inc. report earnings?

    The next expected earnings date for Denali Therapeutics Inc. is November 6, 2025
    On this page